Physician profile
Jared Dendy
NPI 1851610844
$735.61
in general payments reported to CMS, 2019-2025
11 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $18.43 · 2022: $47.91 · 2023: $147 · 2024: $35.41 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $223.92 | 2019-2023 | Tepezza |
| Amgen INC. | $122.19 | 2025 | Tepezza |
| Valeritas, INC. | $102.32 | 2019 | |
| Abbott Laboratories | $69.61 | 2025 | Freestyle Libre 3 |
| Dexcom, INC. | $60.84 | 2022-2025 | Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $51.86 | 2025 | Twiist |
| Insulet Corporation | $32.71 | 2019-2020 | |
| Radius Health, INC. | $24.90 | 2025 | Tymlos |
| Medtronic, INC. | $17.78 | 2024 | Minimed 780g |
| Beta Bionics, INC. | $17.63 | 2024 | Ilet Bionic Pancreas |
| Amneal Pharmaceuticals LLC | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Dendy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.